Home Cart 0 Sign in  
X

[ CAS No. 56241-09-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 56241-09-9
Chemical Structure| 56241-09-9
Chemical Structure| 56241-09-9
Structure of 56241-09-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 56241-09-9 ]

Related Doc. of [ 56241-09-9 ]

Alternatived Products of [ 56241-09-9 ]

Product Details of [ 56241-09-9 ]

CAS No. :56241-09-9 MDL No. :MFCD01861859
Formula : C9H6ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :MVWIXKFNHOXLBU-UHFFFAOYSA-N
M.W : 179.60 Pubchem ID :824649
Synonyms :

Calculated chemistry of [ 56241-09-9 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.58
TPSA : 32.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.2 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.75
Log Po/w (XLOGP3) : 1.68
Log Po/w (WLOGP) : 2.18
Log Po/w (MLOGP) : 2.22
Log Po/w (SILICOS-IT) : 3.22
Consensus Log Po/w : 2.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.63
Solubility : 0.422 mg/ml ; 0.00235 mol/l
Class : Soluble
Log S (Ali) : -1.98
Solubility : 1.86 mg/ml ; 0.0104 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -4.22
Solubility : 0.0108 mg/ml ; 0.00006 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.61

Safety of [ 56241-09-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 56241-09-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 56241-09-9 ]
  • Downstream synthetic route of [ 56241-09-9 ]

[ 56241-09-9 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 56241-09-9 ]
  • [ 15298-58-5 ]
YieldReaction ConditionsOperation in experiment
66% for 4 h; Heating / reflux A solution of 4-chloro-2H-isoquinolin-l-one (Product of Step 2,3. 1 g, 17 mmol) in POC13 (20 mL) was refluxed for 4 h. After cooling and concentration, the residue was extracted with CHC13 (50 ml) and neutralized with IN NaOH. The organic layer was washed with brine, dried over MgS04 and concentrated in vacuo. The crude product was purified by flash column chromatograph (Biotage Flash 40M) eluted with 5percent EtOAc in hexane to give the product (2.3 g, 66percent). 1H NMR (400 MHz, CDC13) b ppm 7.77 (ddd, J=8. 31, 7.09, 1.22 Hz, 1 H), 7.88 (ddd, J=8. 3 1, 7.09, 1.22 Hz, 1 H), 8.23 (d, J=8. 31 Hz, 1 H), 8. 34 (s, 1 H), 8. 36 (d, J=8. 56 Hz, 1 H); MS 198 (M+H) +.
Reference: [1] Patent: WO2005/51410, 2005, A1, . Location in patent: Page/Page column 93
  • 2
  • [ 56241-09-9 ]
  • [ 15298-58-5 ]
Reference: [1] Journal of Organic Chemistry, 1958, vol. 23, p. 1071
  • 3
  • [ 491-30-5 ]
  • [ 223671-80-5 ]
  • [ 56241-09-9 ]
Reference: [1] Patent: US6248738, 2001, B1,
[2] Patent: US2003/199440, 2003, A1,
[3] Patent: EP1077945, 2003, B1,
  • 4
  • [ 491-30-5 ]
  • [ 56241-09-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 10, p. 2341 - 2351
[2] Patent: US6093731, 2000, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 56241-09-9 ]

Chlorides

Chemical Structure| 131002-09-0

[ 131002-09-0 ]

6-Chloroisoquinolin-1(2H)-one

Similarity: 0.85

Chemical Structure| 1386861-46-6

[ 1386861-46-6 ]

2-Chloro-6-methyl-N-phenylbenzamide

Similarity: 0.79

Chemical Structure| 265977-72-8

[ 265977-72-8 ]

(Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide

Similarity: 0.77

Chemical Structure| 1323140-63-1

[ 1323140-63-1 ]

(Z)-N-(1-Chloro-3-oxo-3-(piperidin-1-yl)-1-(p-tolyl)prop-1-en-2-yl)benzamide

Similarity: 0.77

Chemical Structure| 96600-76-9

[ 96600-76-9 ]

4-Chloro-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde

Similarity: 0.75

Amides

Chemical Structure| 131002-09-0

[ 131002-09-0 ]

6-Chloroisoquinolin-1(2H)-one

Similarity: 0.85

Chemical Structure| 1386861-46-6

[ 1386861-46-6 ]

2-Chloro-6-methyl-N-phenylbenzamide

Similarity: 0.79

Chemical Structure| 491-30-5

[ 491-30-5 ]

1-Hydroxyisoquinoline

Similarity: 0.77

Chemical Structure| 265977-72-8

[ 265977-72-8 ]

(Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide

Similarity: 0.77

Chemical Structure| 1323140-63-1

[ 1323140-63-1 ]

(Z)-N-(1-Chloro-3-oxo-3-(piperidin-1-yl)-1-(p-tolyl)prop-1-en-2-yl)benzamide

Similarity: 0.77

Related Parent Nucleus of
[ 56241-09-9 ]

Isoquinolines

Chemical Structure| 131002-09-0

[ 131002-09-0 ]

6-Chloroisoquinolin-1(2H)-one

Similarity: 0.85

Chemical Structure| 491-30-5

[ 491-30-5 ]

1-Hydroxyisoquinoline

Similarity: 0.77

Chemical Structure| 24188-72-5

[ 24188-72-5 ]

5-Methylisoquinolin-1(2H)-one

Similarity: 0.75

Chemical Structure| 1350643-72-9

[ 1350643-72-9 ]

(S)-3-(1-Aminoethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one

Similarity: 0.74

Chemical Structure| 4594-71-2

[ 4594-71-2 ]

2-Methylisoquinolin-1(2H)-one

Similarity: 0.73